Company Directory / research

PrivateFor profitresearchSeoul, South Korea
Mito Immune Therapeutics is a drug research and development biotech company.
Size
11-50 people: larger than 33% of companies with a size listed
Age
8 years old.
Reach
No web traffic ranking listed.
BiotechnologyMedicalPharmaceutical
Funding, as listed
$40B currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Mitoimmune Therapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Mitoimmune Therapeutics may be growing as it is mentioned alongside other companies in the context of treatments for oral mucositis, indicating active involvement in competitive drug development. The company's name appears in multiple news articles, suggesting ongoing relevance in the biotechnology and pharmaceutical industry. Furthermore, the inclusion of Mitoimmune Therapeutics in discussions about market share competition implies that it is a recognized player in the field, which could be indicative of its growth in the sector.
Summaries written by the source dataset, not by us, and not checked.
research in South Korea.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 13,309 companies in South Korea and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.